Crucell Holland BV

About:

Crucell researches and develops products and markets vaccines, proteins and antibodies for the treatment of infectious diseases.

Website: http://www.crucell.com

Twitter/X: janssenglobal

Top Investors: Atlas Venture, Johnson & Johnson

Description:

Crucell N.V. is a global biopharmaceutical company focused on research development, production and marketing of vaccines, proteins and antibodies that prevent and/or treat infectious diseases. Its vaccines are sold in public and private markets worldwide. Crucell's core portfolio includes a vaccine against hepatitis B, a fully-liquid vaccine against five important childhood diseases and a virosome-adjuvanted vaccine against influenza. Crucell also markets travel vaccines, such as the only oral anti-typhoid vaccine, an oral cholera vaccine and the only aluminum-free hepatitis A vaccine on the market.